Bullish
AGIO's Pyrukynd Gets Approval for Thalassemia in Europe
Agios Pharmaceuticals announced that its drug, Pyrukynd (mitapivat), has received approval from the European Commission for the treatment of anemia as...
AGIO
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (2)
Neutral (0)
Bearish (0)
Latest AGIO News
Bullish
Bullish
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia
Avanzanite Bioscience's partner, Agios Pharmaceuticals, has received European Commission approval for PYRUKYND® (mitapivat) for treating anemia associ...
Research AGIO on:
Ad Space